Prevalence of Central Nervous System–Active Polypharmacy Among Older Adults With Dementia in the US-Reference-Cited by-同舟云学术

Prevalence of Central Nervous System–Active Polypharmacy Among Older Adults With Dementia in the US

Published:2021-03-09 Issue:10 Volume:325 Page:952
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Maust Donovan T.¹²³,Strominger Julie²,Kim H. Myra²³,Langa Kenneth M.²³⁴⁵,Bynum Julie P. W.³⁴,Chang Chiang-Hua³⁴,Kales Helen C.⁶,Zivin Kara¹²³,Solway Erica³,Marcus Steven C.⁷

Affiliation:

1. Department of Psychiatry, University of Michigan, Ann Arbor

2. Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan

3. Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor

4. Department of Internal Medicine, University of Michigan, Ann Arbor

5. Institute for Social Research, University of Michigan, Ann Arbor

6. Department of Psychiatry, University of California–Davis, Sacramento

7. School of Social Policy and Practice, University of Pennsylvania, Philadelphia

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2777235/jama_maust_2021_oi_210010_1614735422.71717.pdf

Reference39 articles.

1. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.;Hebert;Neurology,2013

2. The long reach of Alzheimer’s disease: patients, practice, and policy.;Bynum;Health Aff (Millwood),2014

3. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.;Lyketsos;JAMA,2002

4. Assessing the impact of neuropsychiatric symptoms in Alzheimer’s disease: the Neuropsychiatric Inventory Caregiver Distress Scale.;Kaufer;J Am Geriatr Soc,1998

5. Assessment and management of behavioral and psychological symptoms of dementia.;Kales;BMJ,2015

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case Definition for Diagnosed Alzheimer Disease and Related Dementias in Medicare;JAMA Network Open;2024-09-03

2. Looking beyond the neurological diagnosis: considering frailty;The Lancet Neurology;2024-09

3. Frailty for neurologists: perspectives on how frailty influences care planning;The Lancet Neurology;2024-09

4. Prevalence of polypharmacy and factors impacting psychotropic prescribing patterns in women of childbearing potential at inpatient mental health services in Qatar;Neuropsychopharmacology Reports;2024-08-20

5. Prevalence and Correlates of Antipsychotic Medication Use in Oregon Assisted Living;Journal of the American Medical Directors Association;2024-08